Active, not recruitingPhase 2NCT03799874

Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)

Studying Adult acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Brigham and Women's Hospital
Principal Investigator
Rebecca Baron, MD, M.D
Brigham and Women's Hospital
Intervention
Inhaled Carbon Monoxide at 200 ppm(drug)
Enrollment
32 enrolled
Eligibility
18 years · All sexes
Timeline
20192026

Study locations (7)

Collaborators

Massachusetts General Hospital · Weill Medical College of Cornell University · Duke University · Durham VA Medical Center · New York Presbyterian Brooklyn Methodist Hospital · Duke Regional Hospital · U.S. Army Medical Research Acquisition Activity · Washington University School of Medicine

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03799874 on ClinicalTrials.gov

Other trials for Adult acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Adult acute respiratory distress syndrome

← Back to all trials